Synergy Healthcare plc : Accumulation phase
Entry price | Target | Stop-loss | Potential |
---|
GBX 1,357 |
GBX 0 |
GBX 1,290 |
-100% |
---|
The upward trend could spur Synergy Healthcare in coming sessions.
The group displays strong fundamentals. Growth and profitability prospects are encouraging with revenues reaching GBP 420 million this year for a net margin close to 9.5%. Moreover, better results are expected for the coming years.
Graphically, buyers influence has been downsized. The stock is currently in an accumulation phase close to a support level. This area offers an interesting entry point as the share should accelerate in the coming sessions. Weekly moving averages are still well-oriented and support the price progression.
Investors should closely monitor the security near GBp 1352, to take advantage of renewed upward acceleration in the direction of GBp 1458. A stop loss will be placed under GBp 1337.
The content herein constitutes a general investment recommendation, prepared in accordance with provisions aimed at preventing market abuse by Surperformance, the publisher of MarketScreener.com. More specifically, this recommendation is based on factual elements and expresses a sincere, complete, and balanced opinion. It relies on internal or external data, considered reliable as of the date of their release. Nevertheless, this information, and the resulting recommendation, may contain inaccuracies, errors, or omissions, for which Surperformance cannot be held responsible. This recommendation, which in no way constitutes investment advice, may not be suitable for all investor profiles. The reader acknowledges and accepts that any investment in a financial instrument involves risks, for which they assume full responsibility, without recourse against Surperformance. Surperformance commits to disclosing any conflict of interest that may affect the objectivity of its recommendations.